CDE is commissioned by the DOH to conduct the tasks as depicted in the following figure：

• Review of Clinical Trial Protocols for New Drug
• Review of New Drug Application
• Bridging Study Evaluation
• Traditional Chinese Medicine Project
• Premarket Approval
• Investigational Device Exemption
• Consultation
• Taiwan’s Critical Path Program